Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03960684
Other study ID # CP006
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 25, 2019
Est. completion date December 9, 2019

Study information

Verified date May 2024
Source Levita Magnetics
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the safety and effectiveness of the Levita Magnetic Surgical System in patients undergoing colorectal procedures.


Description:

Prospective, multicenter, single-arm, open label study designed to assess the safety and effectiveness of the Levita Magnetic Surgical System in colorectal procedures.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date December 9, 2019
Est. primary completion date December 9, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Subject is at least 18 years of age - Subject is scheduled to undergo elective colorectal surgery Exclusion Criteria: - Significant comorbidities - Subjects with pacemakers, defibrillators, or other electromedical implants - Subjects with ferromagnetic implants - Clinical history of impaired coagulation - Subject has an anatomical abnormality noted after initiation of index procedure that would prevent device use - Subject is not likely to comply with the follow-up evaluation schedule - Subject is participating in another clinical trial

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Levita Magnetic Surgical System
Levita Magnetic Surgical System

Locations

Country Name City State
Chile Hospital del Salvador Santiago

Sponsors (1)

Lead Sponsor Collaborator
Levita Magnetics

Country where clinical trial is conducted

Chile, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number and types of tools required to retract the colon or peri-colorectal tissues Ability to adequately retract the colon, peri-colorectal tissues or adjacent organs to achieve an effective exposure of the target tissue. Adequate retraction is achieved if it is not necessary to replace the Levita Magnetic Surgical System with another instrument to retract these tissues during the procedure. During planned colorectal procedure
Primary Device related Adverse events All adverse events will be recorded and allocated as to relatedness to device, procedure or other. Through 30 days post colorectal procedure/study completion.